List of misoprostol patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7209075 Mobile object locator	Patent 7209075 was granted and assigned to Pfizer on April, 2007 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7209075	April 24, 2007
‌ US Patent 7030242 Selective inhibition of aggrecanase in osteoarthritis treatment	Patent 7030242 was granted and assigned to Pfizer on April, 2006 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7030242	April 18, 2006
‌ US Patent 6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes	Patent 6894041 was granted and assigned to Pfizer on May, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6894041	May 17, 2005
‌ US Patent 6849629 Pyridazinone aldose reductase inhibitors	Patent 6849629 was granted and assigned to Pfizer on February, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6849629	February 1, 2005
‌ US Patent 7232680 Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof	Patent 7232680 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7232680	June 19, 2007
‌ US Patent 7132106 Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof	Patent 7132106 was granted and assigned to Pfizer on November, 2006 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7132106	November 7, 2006
‌ US Patent 7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses	Patent 7405226 was granted and assigned to Pfizer on July, 2008 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7405226	July 29, 2008
‌ US Patent 12023665 Devices and methods for modifying optical properties	Patent 12023665 was granted and assigned to Pfizer on July, 2024 by the United States Patent and Trademark Office.	Pfizer	Pfizer	United States Patent and Trademark Office	12023665	July 2, 2024
‌ US Patent 7118885 Nucleic acid encoding vitamin D receptor related polypeptide	Patent 7118885 was granted and assigned to Pfizer on October, 2006 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7118885	October 10, 2006
‌ US Patent 7387623 Injectable pharmaceutical suspension in a two-chamber vial	Patent 7387623 was granted and assigned to Pfizer on June, 2008 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7387623	June 17, 2008
‌ US Patent 7231074 Method for determining the efficacy of an anti-cancer treatment using image analysis	Patent 7231074 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7231074	June 12, 2007
‌ US Patent 6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof	Patent 6890927 was granted and assigned to Pfizer on May, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6890927	May 10, 2005
‌ US Patent 7101869 2,4-diaminopyrimidine compounds useful as immunosuppressants	Patent 7101869 was granted and assigned to Pfizer on September, 2006 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7101869	September 5, 2006
‌ US Patent 6852719 Glucocorticoid receptor modulators	Patent 6852719 was granted and assigned to Pfizer on February, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6852719	February 8, 2005
‌ US Patent 11884635 Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof	Patent 11884635 was granted and assigned to Pfizer on January, 2024 by the United States Patent and Trademark Office.	Pfizer	Pfizer	United States Patent and Trademark Office	11884635	January 30, 2024
‌ US Patent 11090375 Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof	Patent 11090375 was granted and assigned to Pfizer on August, 2021 by the United States Patent and Trademark Office.	Pfizer	Pfizer	United States Patent and Trademark Office	11090375	August 17, 2021
‌ US Patent 7301023 Chiral salt resolution	Patent 7301023 was granted and assigned to Pfizer on November, 2007 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7301023	November 27, 2007
‌ US Patent 7229615 Method for the purification, recovery, and sporulation of cysts and oocysts	Patent 7229615 was granted and assigned to Pfizer on June, 2007 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7229615	June 12, 2007
‌ US Patent 11147865 Immunogenic compositions and uses thereof	Patent 11147865 was granted and assigned to Pfizer on October, 2021 by the United States Patent and Trademark Office.	Pfizer	Pfizer	United States Patent and Trademark Office	11147865	October 19, 2021
‌ US Patent 6973741 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus	Patent 6973741 was granted and assigned to Pfizer on December, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6973741	December 13, 2005
‌ US Patent 6984403 Azithromycin dosage forms with reduced side effects	Patent 6984403 was granted and assigned to Pfizer on January, 2006 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6984403	January 10, 2006
‌ US Patent 6887472 Anti-IgE vaccines	Patent 6887472 was granted and assigned to Pfizer on May, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6887472	May 3, 2005
‌ US Patent 6869960 N-substituted spiropiperidine compounds as ligands for ORL-1 receptor	Patent 6869960 was granted and assigned to Pfizer on March, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6869960	March 22, 2005
‌ US Patent 7030157 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins	Patent 7030157 was granted and assigned to Pfizer on April, 2006 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7030157	April 18, 2006
‌ US Patent 6846477 One dose vaccination with Mycoplasma hyopneumoniae	Patent 6846477 was granted and assigned to Pfizer on January, 2005 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	6846477	January 25, 2005

...

Results per page:

476 results

0 selected

476 results

0 selected